Table 2.
Post hoc analysis with comparison of the four subgroups in terms of various variables (n = 96)
| Dependent variable | (I) Group | (II) Group | Mean difference (I-II) | Std. error | p value |
|---|---|---|---|---|---|
| Age (years) | HA | ACS | 0.990 | 0.208 | 0.956 |
| PRP | − 4.483 | 0.196 | 0.096 | ||
| STEROID | − 2.830 | 0.194 | 0.449 | ||
| ACS | HA | − 1.040 | 0.208 | 0.956 | |
| PRP | − 5.520 | 0.193 | 0.022 | ||
| STEROID | − 3.870 | 0.192 | 0.173 | ||
| PRP | HA | 4.483 | 0.196 | 0.096 | |
| ACS | 5.520 | 0.193 | 0.022 | ||
| STEROID | 1.653 | 0.179 | 0.781 | ||
| STEROID | HA | 2.830 | 0.194 | 0.449 | |
| ACS | 3.870 | 0.192 | 0.173 | ||
| PRP | − 1.653 | 0.179 | 0.781 | ||
| VAS (at 6 months) | HA | ACS | 1.614 | 0.604 | 0.148 |
| PRP | 0.825 | 0.570 | 0.747 | ||
| STEROID | − 2.421 | 0.566 | 0.008 | ||
| ACS | HA | − 1.614 | 0.604 | 0.148 | |
| PRP | − 0.788 | 0.562 | 0.850 | ||
| STEROID | − 4.035 | 0.558 | < 0.001 | ||
| PRP | HA | − 0.825 | 0.570 | 0.747 | |
| ACS | 0.788 | 0.562 | 0.850 | ||
| STEROID | − 3.247 | 0.521 | < 0.001 | ||
| STEROID | HA | 2.421 | 0.566 | 0.008 | |
| ACS | 4.035 | 0.558 | < 0.001 | ||
| PRP | 3.247 | 0.521 | . < 0.001 | ||
| WOMAC (at 6 months) | HA | ACS | 14.066 | 4.624 | 0.004 |
| PRP | 4.881 | 4.366 | 0.651 | ||
| STEROID | − 16.885 | 4.333 | 0.163 | ||
| ACS | HA | − 14.066 | 4.624 | 0.004 | |
| PRP | − 9.185 | 4.306 | 0.154 | ||
| STEROID | − 30.952 | 4.273 | < 0.001 | ||
| PRP | HA | − 4.881 | 4.366 | 0.651 | |
| ACS | 9.185 | 4.306 | 0.154 | ||
| STEROID | − 21.767 | 3.992 | . < 0.001 | ||
| STEROID | HA | 16.885 | 4.333 | 0.163 | |
| ACS | 30.952 | 4.273 | < 0.001 | ||
| PRP | 21.767 | 3.992 | . < 0.001 | ||
| Percent change in VAS | HA | ACS | 26.03 | 0.604 | 0.133 |
| PRP | 17.86 | 0.562 | 0.532 | ||
| STEROID | − 27.22 | 0.558 | 0.019 | ||
| ACS | HA | − 26.03 | 0.570 | 0/133 | |
| PRP | − 8.17 | 0.562 | 0.951 | ||
| STEROID | − 53.25 | 0.521 | < 0.001 | ||
| PRP | HA | − 17.86 | 0.566 | 0.532 | |
| ACS | 8.17 | 0.558 | 0.951 | ||
| STEROID | − 45.08 | 0.521 | < 0.001 | ||
| STEROID | HA | 27.22 | 4.624 | 0.019 | |
| ACS | 53.25 | 4.366 | < 0.001 | ||
| PRP | 45.08 | 4.333 | < 0.001 | ||
| Percent change in WOMAC | HA | ACS | 34.59 | 4.624 | 0.002 |
| PRP | 24.20 | 4.306 | 0.061 | ||
| STEROID | − 35.50 | 4.273 | 0.510 | ||
| ACS | HA | − 34.59 | 4.366 | 0.002 | |
| PRP | − 10.39 | 4.306 | 0.785 | ||
| STEROID | − 70.11 | 3.992 | < 0.001 | ||
| PRP | HA | − 24.20 | 4.333 | 0.061 | |
| ACS | 10.39 | 4.273 | 0.785 | ||
| STEROID | − 59.72 | 3.992 | < 0.001 | ||
| STEROID | HA | 35.50 | 4.273 | 0.510 | |
| ACS | 70.11 | 4.366 | < 0.001 | ||
| PRP | 59.72 | 4.306 | < 0.001 |
Post hoc pairwise tests for ANOVA performed using Tukey HSD method. Post hoc pairwise tests for Kruskal–Wallis test performed using Dunn test method with Sidak correction